287 related articles for article (PubMed ID: 19833796)
1. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.
Petersen TA; Morrison LA; Schrader RM; Hart BL
AJNR Am J Neuroradiol; 2010 Feb; 31(2):377-82. PubMed ID: 19833796
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
[TBL] [Abstract][Full Text] [Related]
3. Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.
Choquet H; Nelson J; Pawlikowska L; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H
Cerebrovasc Dis; 2014; 37(1):57-63. PubMed ID: 24401931
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
Gault J; Sain S; Hu LJ; Awad IA
Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
[TBL] [Abstract][Full Text] [Related]
5. Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.
D'Angelo R; Alafaci C; Scimone C; Ruggeri A; Salpietro FM; Bramanti P; Tomasello F; Sidoti A
Biomed Res Int; 2013; 2013():459253. PubMed ID: 24058906
[TBL] [Abstract][Full Text] [Related]
6. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
7. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations.
Verlaan DJ; Laurent SB; Sure U; Bertalanffy H; Andermann E; Andermann F; Rouleau GA; Siegel AM
Neurology; 2004 Apr; 62(7):1213-5. PubMed ID: 15079030
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
[TBL] [Abstract][Full Text] [Related]
10. Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.
Scimone C; Bramanti P; Alafaci C; Granata F; Piva F; Rinaldi C; Donato L; Greco F; Sidoti A; D'Angelo R
J Mol Neurosci; 2017 Feb; 61(2):189-198. PubMed ID: 28000143
[TBL] [Abstract][Full Text] [Related]
11. How Relevant Is Occlusion of Associated Developmental Venous Anomaly in Cerebral Cavernoma Surgery? A Clinical and Radiographic Comparison Study.
Tantongtip D; Spetzger U; Arnold S; von Schilling A; Kiriyanthan G
J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):111-7. PubMed ID: 26444962
[TBL] [Abstract][Full Text] [Related]
12. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
[TBL] [Abstract][Full Text] [Related]
13. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar cavernous malformations with and without associated developmental venous anomalies.
Zhang P; Liu L; Cao Y; Wang S; Zhao J
BMC Neurol; 2013 Oct; 13():134. PubMed ID: 24088363
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.
Choquet H; Trapani E; Goitre L; Trabalzini L; Akers A; Fontanella M; Hart BL; Morrison LA; Pawlikowska L; Kim H; Retta SF
Free Radic Biol Med; 2016 Mar; 92():100-109. PubMed ID: 26795600
[TBL] [Abstract][Full Text] [Related]
16. DNA promoter methylation of CCM genes in human cerebral cavernous malformations: Importance of confirming MSP data through sequencing.
Saban D; Larisch J; Nickel AC; Pierscianek D; Dammann P; Sure U; Zhu Y
Eur J Med Genet; 2020 Dec; 63(12):104090. PubMed ID: 33122157
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age.
Brinjikji W; El-Masri AE; Wald JT; Flemming KD; Lanzino G
Childs Nerv Syst; 2017 Sep; 33(9):1539-1543. PubMed ID: 28643038
[TBL] [Abstract][Full Text] [Related]
18. Increased number of white matter lesions in patients with familial cerebral cavernous malformations.
Golden MJ; Morrison LA; Kim H; Hart BL
AJNR Am J Neuroradiol; 2015 May; 36(5):899-903. PubMed ID: 25556204
[TBL] [Abstract][Full Text] [Related]
19. CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study.
D'Angelo R; Scimone C; Rinaldi C; Trimarchi G; Italiano D; Bramanti P; Amato A; Sidoti A
Int J Mol Med; 2012 Jun; 29(6):1113-20. PubMed ID: 22378217
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
Jaman E; Abdallah HM; Zhang X; Greene S
J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
